Norris Medicines Ltd. Share Price & Stock Analysis

Norris Medicines Ltd. (BSE: 524414) is an Ankleshwar, Gujarat-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹14 Cr, it ranks #4,611 by market cap among the 6,197 Indian listed companies on FinBizNet, and #24 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹14.16 (as of 16 Nov 2026), the share price is 29.4% below its 52-week high of ₹20.06 and 18.0% above its 52-week low of ₹12.00. The share price is down 8.1% over one year and down 13.2% over three months.

Key Metrics

Current Price₹14.16
Market Cap₹14 Cr
BSE Code524414
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
P/E RatioNot meaningful (loss)
Return on Equity1.87%
Return on Assets0.88%
52-Week Range₹12.00 – ₹20.06
1-Year Price Change-8.1%
3-Month Price Change-13.2%
Beta (1Y)0.23
HeadquartersAnkleshwar, Gujarat
Websitewww.norrispharma.com

Shareholding and Delivery

Delivery averaged 94.8% of traded volume across 14 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Norris Medicines Ltd.

Norris Medicines Limited manufactures and sells pharmaceutical formulations in India. The company offers nonsterile dosage products, such as tablets, capsules, liquid orals, and copical ointments, as well as injections and medicinal formulations. Its products include antibiotics, anti-inflammatory/pain management, antiemetic, nutrition, gastro, cough/cold, skin and allergy, antimalarial, diabetic, cardiac, dental, and other medicine products. The company also provides contract and loan license manufacturing services for pharma companies. It exports its products. Norris Medicines Limited was incorporated in 1990 and is based in Ankleshwar, India.

Products and Services

1. Pharmaceuticals-This segment engages in the contract manufacturing and loan license manufacturing for various multinational and Indian pharma companies.

Business Segments

1. Pharmaceuticals-100%

Norris Medicines Ltd. vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Norris Medicines Ltd.₹14 Crn/m1.87%—-8.1%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Norris Medicines Ltd.?

Norris Medicines Ltd. is trading at ₹14.16, with a market capitalisation of ₹14 Cr.

Which sector does Norris Medicines Ltd. belong to?

Norris Medicines Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What are the key financial ratios of Norris Medicines Ltd.?

Norris Medicines Ltd. has a return on equity of 1.87%.

What is the stock symbol of Norris Medicines Ltd.?

Norris Medicines Ltd. is listed on the BSE under the scrip code 524414.

How has Norris Medicines Ltd.'s share price moved over the past year?

Norris Medicines Ltd.'s share price is down 8.1% over one year and down 13.2% over three months. Its 52-week range is ₹12.00 to ₹20.06.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.